[1]
M. Sofronievska-Glavinov, S. Jovevska, and M. Kocubovski, “Quality of life assessment in patients treated with medicaments for benign prostatic hyperplasia”, Arch Pub Health, vol. 11, no. 1, pp. 89–94, Apr. 2019.